| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11026838 | Materials Science and Engineering: C | 2019 | 22 Pages |
Abstract
Drug functionalized scaffolds are currently being employed to improve local delivery of osteoprotective drugs with the aim of reducing their loading dose as well as unwanted systemic complications. In this study we tested a poly-(ε) caprolactone (PCL)-laponite-strontium ranelate (SRA) composite scaffold (PLS3) for its abilities to support growth and osteogenic differentiation of human marrow derived stromal stem cells (hMSC). The in vitro experiments showed the PLS3 scaffold supported cell growth and osteogenic differentiation. The in vivo implantation of hMSC seeded PLS3 scaffold in immunocompromised mice revealed vascularized ectopic bone formation. PLS3 scaffolds can be useful in bone regenerative applications in the fields of orthopaedics and dentistry.
Related Topics
Physical Sciences and Engineering
Materials Science
Biomaterials
Authors
Rahul D. Prabha, Bindu P. Nair, Nicholas Ditzel, Jorgen Kjems, Prabha D. Nair, Moustapha Kassem,